$159.55
8.855.87%
At close: -
$159.55
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Stride Analyst Ratings and Price Targets | NYSE:LRN | Benzinga
Stride Inc has a consensus price target of $106.13 based on the ratings of 8 analysts. The high is $170 issued by Barrington Research on April 30, 2025. The low is $43 issued by Morgan Stanley on October 27, 2022. The 3 most-recent analyst ratings were released by Barrington Research, Canaccord Genuity, and Barrington Research on April 30, 2025, April 28, 2025, and April 17, 2025, respectively. With an average price target of $158.33 between Barrington Research, Canaccord Genuity, and Barrington Research, there's an implied -0.76% downside for Stride Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barrington Research
Canaccord Genuity
BMO Capital
Morgan Stanley
Citigroup
1calculated from analyst ratings
Analyst Ratings for Stride
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/30/2025 | Buy Now | 6.55% | Barrington Research | Alexander Paris82% | $150 → $170 | Maintains | Outperform | Get Alert |
| 04/28/2025 | Buy Now | -2.85% | Canaccord Genuity | Jason Tilchen57% | $145 → $155 | Maintains | Buy | Get Alert |
| 04/17/2025 | Buy Now | -5.99% | Barrington Research | Alexander Paris82% | $140 → $150 | Maintains | Outperform | Get Alert |
| 04/01/2025 | Buy Now | -12.88% | BMO Capital | Jeffrey Silber76% | $134 → $139 | Maintains | Outperform | Get Alert |
| 03/14/2025 | Buy Now | -12.25% | Barrington Research | Alexander Paris82% | $140 → $140 | Maintains | Outperform | Get Alert |
| 03/11/2025 | Buy Now | -9.12% | Canaccord Genuity | Jason Tilchen57% | $135 → $145 | Maintains | Buy | Get Alert |
| 01/30/2025 | Buy Now | -16.01% | BMO Capital | Jeffrey Silber76% | $122 → $134 | Maintains | Outperform | Get Alert |
| 01/29/2025 | Buy Now | -12.25% | Barrington Research | Alexander Paris82% | $130 → $140 | Maintains | Outperform | Get Alert |
| 01/29/2025 | Buy Now | -15.39% | Canaccord Genuity | Jason Tilchen57% | $130 → $135 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | -18.52% | Canaccord Genuity | Jason Tilchen57% | $100 → $130 | Maintains | Buy | Get Alert |
| 01/17/2025 | Buy Now | -18.52% | Barrington Research | Alexander Paris82% | $100 → $130 | Maintains | Outperform | Get Alert |
| 12/12/2024 | Buy Now | -31.68% | Morgan Stanley | Greg Parrish75% | $94 → $109 | Maintains | Equal-Weight | Get Alert |
| 10/29/2024 | Buy Now | -41.08% | Citigroup | Thomas Singlehurst72% | $90 → $94 | Maintains | Neutral | Get Alert |
| 10/24/2024 | Buy Now | -44.84% | BMO Capital | Jeffrey Silber76% | $84 → $88 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | -37.32% | Barrington Research | Alexander Paris82% | $90 → $100 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | -37.32% | Canaccord Genuity | Jason Tilchen57% | $94 → $100 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | -43.59% | Barrington Research | Alexander Paris82% | $90 → $90 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | -43.59% | Barrington Research | Alexander Paris82% | $90 → $90 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | -43.59% | Citigroup | Thomas Singlehurst72% | $77 → $90 | Downgrade | Buy → Neutral | Get Alert |
| 08/08/2024 | Buy Now | -43.59% | Barrington Research | Alexander Paris82% | $85 → $90 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | -48.61% | BMO Capital | Jeffrey Silber76% | $79 → $82 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | -41.08% | Canaccord Genuity | — | → $94 | Initiates | → Buy | Get Alert |
| 07/31/2024 | Buy Now | -46.73% | Barrington Research | Alexander Paris82% | $75 → $85 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | -54.25% | BMO Capital | Jeffrey Silber76% | $72 → $73 | Maintains | Outperform | Get Alert |
| 04/24/2024 | Buy Now | -52.99% | Barrington Research | Alexander Paris82% | $75 → $75 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | -52.99% | Barrington Research | Alexander Paris82% | $75 → $75 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | -52.99% | Citigroup | Thomas Singlehurst72% | $70 → $75 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | -54.87% | BMO Capital | Jeffrey Silber76% | $71 → $72 | Maintains | Outperform | Get Alert |
| 01/24/2024 | Buy Now | -59.26% | Morgan Stanley | Greg Parrish75% | $60 → $65 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | Buy Now | -52.99% | Barrington Research | Alexander Paris82% | $70 → $75 | Maintains | Outperform | Get Alert |
| 12/04/2023 | Buy Now | -56.13% | Barrington Research | Alexander Paris82% | → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 11/16/2023 | Buy Now | -58.01% | BMO Capital | Jeffrey Silber76% | $57 → $67 | Maintains | Outperform | Get Alert |
| 11/16/2023 | Buy Now | -62.39% | Morgan Stanley | Greg Parrish75% | $57 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/26/2023 | Buy Now | -64.27% | BMO Capital | Jeffrey Silber76% | $50 → $57 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -62.39% | Barrington Research | Alexander Paris82% | $50 → $60 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -64.27% | Morgan Stanley | Greg Parrish75% | $52 → $57 | Maintains | Equal-Weight | Get Alert |
| 08/16/2023 | Buy Now | -68.66% | Barrington Research | Alexander Paris82% | → $50 | Reiterates | Outperform → Outperform | Get Alert |
| 08/16/2023 | Buy Now | -67.41% | Morgan Stanley | Greg Parrish75% | $50 → $52 | Maintains | Equal-Weight | Get Alert |
| 08/16/2023 | Buy Now | -68.66% | BMO Capital | Jeffrey Silber76% | $49 → $50 | Maintains | Outperform | Get Alert |
| 04/26/2023 | Buy Now | -68.66% | Morgan Stanley | Greg Parrish75% | $46 → $50 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | Buy Now | -68.66% | Barrington Research | Alexander Paris82% | → $50 | Reiterates | → Outperform | Get Alert |
| 03/10/2023 | Buy Now | -71.17% | Morgan Stanley | Greg Parrish75% | → $46 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/26/2023 | Buy Now | -69.92% | BMO Capital | Jeffrey Silber76% | $47 → $48 | Maintains | Outperform | Get Alert |
| 01/25/2023 | Buy Now | -68.66% | Barrington Research | Alexander Paris82% | → $50 | Reiterates | → Outperform | Get Alert |
| 01/25/2023 | Buy Now | -71.17% | Morgan Stanley | Greg Parrish75% | $41 → $46 | Maintains | Overweight | Get Alert |
| 01/04/2023 | Buy Now | -74.3% | Morgan Stanley | Greg Parrish75% | $43 → $41 | Maintains | Overweight | Get Alert |
| 10/27/2022 | Buy Now | -68.66% | BMO Capital | Jeffrey Silber76% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/27/2022 | Buy Now | -73.05% | Morgan Stanley | Toni Kaplan67% | $47 → $43 | Maintains | Overweight | Get Alert |
| 09/27/2022 | Buy Now | -70.54% | Morgan Stanley | Toni Kaplan67% | $45 → $47 | Maintains | Overweight | Get Alert |
| 08/25/2022 | Buy Now | -71.8% | Morgan Stanley | Greg Parrish75% | → $45 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/10/2022 | Buy Now | -71.8% | Morgan Stanley | Jeffrey Goldstein71% | $42 → $45 | Maintains | Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | -73.68% | Morgan Stanley | Jeffrey Goldstein71% | $39 → $42 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Stride (LRN) stock?
The latest price target for Stride (NYSE:LRN) was reported by Barrington Research on April 30, 2025. The analyst firm set a price target for $170.00 expecting LRN to rise to within 12 months (a possible 6.55% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Stride (LRN)?
The latest analyst rating for Stride (NYSE:LRN) was provided by Barrington Research, and Stride maintained their outperform rating.
When was the last upgrade for Stride (LRN)?
The last upgrade for Stride Inc happened on August 25, 2022 when Morgan Stanley raised their price target to $45. Morgan Stanley previously had an equal-weight for Stride Inc.
When was the last downgrade for Stride (LRN)?
The last downgrade for Stride Inc happened on August 20, 2024 when Citigroup changed their price target from $77 to $90 for Stride Inc.
When is the next analyst rating going to be posted or updated for Stride (LRN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stride, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stride was filed on April 30, 2025 so you should expect the next rating to be made available sometime around April 30, 2026.
Is the Analyst Rating Stride (LRN) correct?
While ratings are subjective and will change, the latest Stride (LRN) rating was a maintained with a price target of $150.00 to $170.00. The current price Stride (LRN) is trading at is $159.55, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
